Clinical Impact of Lymphadenectomy Extent in Resectable Esophageal Cancer
- 1 November 2007
- journal article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 11 (11) , 1384-1394
- https://doi.org/10.1007/s11605-007-0264-2
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Hospital Volume and Late Survival After Cancer SurgeryAnnals of Surgery, 2007
- An Evaluation of Prognostic Factors and Tumor Staging of Resected Carcinoma of the EsophagusAnnals of Surgery, 2007
- American Joint Committee on Cancer Staging System Does Not Accurately Predict Survival in Patients Receiving Multimodality Therapy for Esophageal AdenocarcinomaJournal of Clinical Oncology, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resectionBest Practice & Research Clinical Gastroenterology, 2006
- Adenocarcinoma of the Gastroesophageal Junction: Benefits of an Extended LymphadenectomySurgical Oncology Clinics of North America, 2006
- A comparison of transhiatal and transthoracic resections on the prognosis in patients with squamous cell carcinoma of the esophagusEuropean Journal of Surgical Oncology, 2006
- Early Esophageal CancerAnnals of Surgery, 2005
- Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junctionEuropean Journal of Surgical Oncology, 2005
- A Prospective Randomized Trial of Extended Cervical and Superior Mediastinal Lymphadenectomy for Carcinoma of the Thoracic EsophagusThe American Journal of Surgery, 1998